4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-20-028940
Director sold 26,250 shares at $51.13 ($1,342,178)
- Director acquired 26,250 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Daly James M Director | 2020-05-11 | Option exercise | +11,250 | $25.24 | $283,950 | 11,250 | D |
| Daly James M Director | 2020-05-11 | Option exercise | +15,000 | $27.25 | $408,750 | 26,250 | D |
| Daly James M Director | 2020-05-11 | Sale | −26,250 | $51.13 | $1,342,178 | 0 | D |
| Derivatives | |||||||
| Daly James M Director | 2020-05-11 | Option exercise · Stock Option (Right to Buy) | −11,250 | 11,250 | D | ||
| Daly James M Director | 2020-05-11 | Option exercise · Stock Option (Right to Buy) | −15,000 | 0 | D | ||
| Open-market sales · 26,250 sh · avg $51.13 · $1,342,178 | |||||||
Loading xslF345X03/doc4.xml…